DEPO-PROVERA - NEW DEVELOPMENTS IN A DECADE-OLD CONTROVERSY

[1] EHRENREICH B, 1979, MOTHER JONES NOV, P26

[2] FOUNTAIN LH, 1974, COMMUNICATION 1002

[3] *INT PLANN PAR FED, 1980, CONCL INT MED ADV PA

[4] DEPO - DEBATE CONTINUES [J]. FAMILY PLANNING PERSPECTIVES, 1978, 10 (06): : 342 - 345

[5] *MIN SANT SEC SOC, 1980, DIR PHARM MED

[6] *NAT WOM HLTH NETW, NAT NEWS AL DEP POV

[7] PARDTHAISONG T, 1980, LANCET, V1, P509

[8] DALKON SHIELD - TALE OF A TAIL [J]. FAMILY PLANNING PERSPECTIVES, 1974, 6 (04): : 198 - 201

[9] *WHO SPEC PROGR RE, 1979, 8TH ANN REP

[10] 1978, FDA DRUG B, V8, P10

[1] EHRENREICH B, 1979, MOTHER JONES NOV, P26

[2] FOUNTAIN LH, 1974, COMMUNICATION 1002

[3] *INT PLANN PAR FED, 1980, CONCL INT MED ADV PA

[4] DEPO - DEBATE CONTINUES [J]. FAMILY PLANNING PERSPECTIVES, 1978, 10 (06): : 342 - 345

[5] *MIN SANT SEC SOC, 1980, DIR PHARM MED

[6] *NAT WOM HLTH NETW, NAT NEWS AL DEP POV

[7] PARDTHAISONG T, 1980, LANCET, V1, P509

[8] DALKON SHIELD - TALE OF A TAIL [J]. FAMILY PLANNING PERSPECTIVES, 1974, 6 (04): : 198 - 201

[9] *WHO SPEC PROGR RE, 1979, 8TH ANN REP

[10] 1978, FDA DRUG B, V8, P10